Figure 3

Kaplan–Meier curves compare the cumulative probability for progression-free survival and overall survival among peritoneal mesotheliomas with homozygous CDKN2A deletions (a and b, respectively) and hemizygous NF2 loss (c and d, respectively). Patients with both homozygous CDKN2A deletion and hemizygous NF2 loss had a shorter progression-free survival (e), and worse overall survival (f) than patients with alterations in either gene alone. The P-values were calculated using a log-rank test.